Building a successful healthcare company takes more than funding. It takes the right leadership, credible clinical evidence, commercial traction and the ability to execute. Through Henry's involvement with the Horizon 11 Venture Capital Fund, Titan connects hands-on talent and commercial capability with an operator-led healthcare investment approach.
Horizon 11 Venture Capital Fund is being developed to back healthcare technology businesses with the potential to scale internationally, combining investment capital with practical support across leadership, commercial strategy, clinical validation and market expansion.
A central part of the strategy is to use the UAE and wider GCC as a platform for building partnerships, generating clinical evidence and establishing commercial traction, supporting expansion into the US and other international markets.
The ambition is to build stronger, more investable businesses: companies with capable management teams, a clear route to profitability and the foundations for future funding, strategic acquisition or public-market opportunities.
Executive search, board development and fractional leadership to build the teams that deliver growth.
Strategy, partnerships and practical support across the US, Europe and the GCC.
Through Henry's partnership with datosX, introductions for early-stage companies seeking clinical validation and engagement with leading US healthcare systems.
Helping founders articulate the investment case, address capability gaps and execute against key milestones, with a potential Horizon 11 investment route for suitable companies.
Horizon 11 investment consideration is separate from Titan's services and subject to the fund's mandate, due diligence and approvals. Engagement with Titan does not guarantee investment.